Abstract
A Longitudinal Toxicity over Time (ToxT) Analysis of Bortezomib When Added to Bendamustine-Rituximab (BR) in Previously Untreated High Risk (HR) Follicular Lymphoma (FL) from in E2408
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have